The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Market Overview

• Strong Recent Growth: The oral solid dosage pharmaceutical formulation market has seen robust expansion, growing from $583.07 billion in 2023 to an estimated $618.34 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.0%.
• Future Projections: This growth is expected to continue, with the market projected to reach $792.37 billion by 2028, growing at a CAGR of 6.4%.
• Driving Factors: Key contributors to this growth include the increasing prevalence of chronic diseases, an aging population, expanded healthcare access, promotion of generic formulations, and shifts in consumer preferences.

Historical Growth Drivers

• Chronic Disease Prevalence: The rising prevalence of chronic diseases such as diabetes and heart conditions has significantly driven market growth. These conditions require long-term medication, making oral solid dosages, like tablets and capsules, crucial for treatment adherence.
• Aging Population: As the global population ages, the demand for convenient and effective pharmaceutical solutions grows, particularly in managing age-related conditions.
• Expanded Healthcare Access: Improved access to healthcare services worldwide has increased the demand for medications, further boosting the market.
• Promotion of Generics: The promotion and acceptance of generic formulations have made medications more accessible, contributing to market growth.
• Consumer Preference Shifts: Consumers are increasingly opting for oral solid dosages due to their ease of use, stability, and precise dosing.

View More On The Oral Solid Dosage Pharmaceutical Formulation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-pharmaceutical-formulation-global-market-report

Future Growth Drivers

• Personalized Medicine: The growing demand for personalized medicine is expected to be a major driver. This approach tailors treatments to individual patients, enhancing efficacy and minimizing side effects.
• Controlled-Release Adoption: Controlled-release formulations are gaining popularity for their ability to deliver medication over an extended period, improving patient compliance and treatment outcomes.
• Biopharmaceutical Focus: The industry is increasingly focusing on biopharmaceuticals, which often require specialized oral solid dosage formulations.
• Emerging Market Expansion: Expanding into emerging markets will provide new growth opportunities, particularly in regions with increasing healthcare infrastructure.
• Policy and Reimbursement Changes: Evolving healthcare policies and reimbursement frameworks are expected to support market growth by making innovative therapies more accessible.

Trends Shaping the Future

• Personalized Medicine Adoption: This trend will drive demand for custom oral solid dosages tailored to individual patient needs.
• Digital Health Integration: The integration of digital health technologies, such as telemedicine and remote monitoring, will support the administration and management of oral solid dosages.
• Preventive Healthcare Focus: The growing emphasis on preventive healthcare will boost demand for medications aimed at preventing chronic diseases.
• Artificial Intelligence (AI) in Healthcare: AI’s role in drug discovery and patient management is expected to continue expanding, influencing the development and optimization of oral solid dosages.

Innovations in Drug Delivery

• Liquid-Filled Capsules: Companies are innovating with liquid-filled capsules to enhance drug delivery. These capsules improve bioavailability, offer precise dosing, and ensure better patient compliance. For example, Zeon Lifesciences Ltd. launched liquid-filled capsules in 2023, featuring advanced technologies that enhance medication absorption and patient outcomes.

Strategic Acquisitions

• Roquette Frères’ Expansion: In March 2024, Roquette Frères, a France-based company, expanded into the pharmaceutical industry by acquiring IFF Pharma Solutions for $2.85 billion. This acquisition enhances Roquette’s formulation capabilities and strengthens its global presence, positioning it as a key player in the oral solid dosage market.

Market Segmentation and Regional Insights

• Segmentation: The market is segmented by dosage form (tablets, capsules, powders, and more), mechanism (controlled-release, immediate-release), distribution channel (hospital pharmacies, retail pharmacies, etc.), and end-user (large companies, small companies).
• Regional Insights: North America was the largest market in 2023, with Asia-Pacific expected to be the fastest-growing region during the forecast period.

The oral solid dosage pharmaceutical formulation market is poised for sustained growth, driven by innovations, strategic expansions, and the evolving needs of patients and healthcare providers.

Request A Sample Of The Global Oral Solid Dosage Pharmaceutical Formulation Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15626&type=smp